The NHRMC provided $673.7 million through 1140 grants to researchers and projects around the country, the biggest ever investment in health and medical research in Australia’s history.
Victoria receive the highest amount of funding of all the states and territories, with $278.2 million.
Burnet Institute Director and CEO Professor Brendan Crabb said the Institute greatly appreciates the support of the NHMRC.
“These funds will go a long way toward identifying better ways to treat and prevent major infectious disease of mankind and to tackle the health risks associated with drug use in our society,” Professor Crabb said.
Please see below for a full list of recipients with their project names.
Project Grants commencing 2012
Professor Louisa Degenhardt - Pharmaceutical opioid prescription for chronic pain in Australia: Trajectories of prescribing, risk of adverse events, and predictors of harm. ($1,041,601)
“There is concern about rising levels of opioid analgesic prescribing in Australia. This study is important because it will provide evidence about long term outcomes for patient using opioid therapy for chronic non-malignant pain.”
Dr Mark Stoove - A prospective cohort study of ex-prisoners with a history of injecting drug use: examining health service utilisation, physical and mental health and blood borne virus trajectories. ($956,019.50)
“This is an important opportunity to inform health policy and practice for one of the most socially disadvantaged groups in Australia. We know surprisingly little about this extremely vulnerable period, as prisoners with drug dependence transition into the community.”
Associate Professor Paul Gorry - Elucidating unique molecular mechanisms involved in HIV-1 subtype C pathogenicity. ($686,365)
“This grant will enable us to continue our work on understanding how HIV subtype C, the most prevalent yet least understood HIV subtype, causes disease in Africa and other resource poor regions.”
Associate Professor Heidi Drummer - Roles of the hepatitis C virus glycoprotein E2 variable regions in virus entry, immunogenicity and immune evasion. ($659,685)
“This is a fantastic outcome that reflects many years hard work from the scientists in the Fusion Lab. The project grant will enable us to further understand the mechanisms of immune invasion in HCV and how to develop vaccines to prevent infection.”
Associate Professor Gilda Tachedjian - Lactic acid as a natural microbicide for HIV. ($577,350)
“Absolutely thrilled – now we can investigate how lactic acid found in the healthy vaginal tract disables HIV which has implications in the development of topical microbicides to prevent the sexual transmission of HIV.”
Professor Steve Gerondakis - The NF-kB transcription factors c-Rel and RelA control multiple steps in natural CD4 regulatory T cell development. ($548,005)
Early Career Fellowships for funding commencing in 2012
Dr Jack Richards - Antibodies to the invasion ligand EBA175 and protection from plasmodium falciparum malaria. ($354,892)
“Although these fellowships are awarded to an individual, they reflect the hard work of a team. Thank all those that have supported me in the last few years, especially James Beeson and the other members of the Beeson Lab. These fellowships will enable us to continue our work in studying the immune responses that protect children from clinical malaria, and to assist in malaria vaccine development.”